Spravato®

Spravato® is an FDA-approved nasal spray treatment designed for adults with treatment-resistant depression. It is derived from ketamine, offering rapid relief for those who haven’t found success with traditional antidepressants. This innovative therapy works by targeting neurotransmitters to improve mood and reduce depressive symptoms.

Spravato® affects glutamate, a key neurotransmitter involved in mood regulation. Unlike conventional antidepressants, it delivers results more quickly, often within hours or days. Administered under medical supervision, Spravato® is combined with oral antidepressants to maximize its effectiveness.

Pathway Healthcare proudly offers Spravato® treatment at our Birmingham, AL, Huntsville, AL,  Columbus, MS, and Flowood, MS clinics. Our experienced team ensures a safe, supportive environment during each treatment session. We are committed to providing individualized care and helping patients achieve lasting mental wellness.

Spravato® is recommended for individuals with major depressive disorder (MDD) who have not responded to at least two previous antidepressant treatments. Consult with our team to discuss your mental health history and determine if this therapy is the right fit for your needs.

For more detailed information about Spravato®, visit the official Spravato® website or schedule a consultation at Pathway Healthcare. We’re here to answer your questions and guide you on your path to recovery.